About Company
In early 2007, VGX™ Animal Health acquired the portfolio of DNA based therapies of ADViSYS, which was originally developed for animal health. With over a decade of experience, VGX Animal Health has positioned itself to lead the animal health industry.
The current portfolio of intellectual property and technology is the evolution of work initiated in the Baylor College of Medicine Laboratory of Dr. Robert Schwartz and Dr. Ruxandra Draghia. Following initial
In early 2007, VGX™ Animal Health acquired the portfolio of DNA based therapies of ADViSYS, which was originally developed for animal health. With over a decade of experience, VGX Animal Health has positioned itself to lead the animal health industry.
The current portfolio of intellectual property and technology is the evolution of work initiated in the Baylor College of Medicine Laboratory of Dr. Robert Schwartz and Dr. Ruxandra Draghia. Following initial studies at Baylor the technology was transferred to a Baylor College of Medicine Technology (BCMT) start-up company named Applied Veterinary Systems, Inc. which was renamed ADViSYS Inc. in 2001.
The mission since inception has been to develop and commercialize animal applications for our proprietary plasmid-based growth hormone releasing hormone technology, utlilizing Inovio's delivery device (CELLECTRA® electroporator), but has evolved to add the development of DNA Vaccines.
